The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Demographic, tumor characteristics, and outcomes associated with SMAD4 mutation in colorectal cancer.
 
Amir Mehrvarz Sarshekeh
No Relationships to Disclose
 
Michael J. Overman
No Relationships to Disclose
 
Bryan K. Kee
No Relationships to Disclose
 
David R. Fogelman
Stock and Other Ownership Interests - GTx
Consulting or Advisory Role - Incyte
 
Arvind Dasari
No Relationships to Disclose
 
Kanwal Pratap Singh Raghav
No Relationships to Disclose
 
Eduardo Vilar Sanchez
No Relationships to Disclose
 
Shanequa Manuel
No Relationships to Disclose
 
Imad Shureiqui
No Relationships to Disclose
 
Robert A. Wolff
No Relationships to Disclose
 
Keyur Patel
No Relationships to Disclose
 
Rajyalakshmi Luthra
No Relationships to Disclose
 
Kenna Rael Shaw
No Relationships to Disclose
 
Cathy Eng
Honoraria - Lilly; Roche; Sanofi
Consulting or Advisory Role - Bayer Schering Pharma; Roche/Genentech
Research Funding - ArQule; Keryx
Travel, Accommodations, Expenses - Genentech/Roche
 
Dipen M. Maru
No Relationships to Disclose
 
Mark Routbort
No Relationships to Disclose
 
Funda Meric-Bernstam
Honoraria - Genentech; Roche; Sysmex
Consulting or Advisory Role - Genentech; Inflection Biosciences; Novartis; Roche
Research Funding - AstraZeneca; Bayer; Calithera Biosciences; Debiopharm Group; Genentech; Novartis; Taiho Pharmaceutical
 
Scott Kopetz
Consulting or Advisory Role - Agendia; Amgen; Array BioPharma; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Merrimack; Roche; Sanofi; Sysmex; Taiho Pharmaceutical
Research Funding - Agendia; Amgen; Biocartis; GlaxoSmithKline; Guardant Health; Roche; Sanofi; Sysmex